The main aim of the solution is to automate and accelerate the discovery of new drugs and treatment possibilities. With help of  artificial intelligence based model, the pharmaceutical companies, patients, and society are benefited at large with scalable and cost-effective solutions.  This open platform integrates multiple datatypes which helps to increase efficiency of analysis and improves success for bio marker development . It also deals with histology images where the texture, spectral and structural features such of the nucleus are identified with the help of Image processing.   The intent of this project is train Computer Vision-based Deep Learning models that can classify pathology image tiles as benign or malignant.